Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study

The phase III DATA study investigates the efficacy of adjuvant anastrozole (6 vs. 3 year) in postmenopausal women with breast cancer previously treated with 2–3 years of tamoxifen. This planned side‐study assessed patterns of care regarding detection and treatment of osteopenia/osteoporosis, and tre...

Descripción completa

Detalles Bibliográficos
Autores principales: van Hellemond, Irene E.G., Smorenburg, Carolien H., Peer, Petronella G.M., Swinkels, Astrid C.P., Seynaeve, Caroline M., van der Sangen, Maurice J.C., Kroep, Judith R., de Graaf, Hiltje, Honkoop, Aafke H., Erdkamp, Frans L.G., van den Berkmortel, Franchette W.P.J., de Boer, Maaike, de Roos, Wilfred K., Linn, Sabine C., Imholz, Alexander L.T., Tjan‐Heijnen, Vivianne C.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Cancer Therapy and Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767695/
https://www.ncbi.nlm.nih.gov/pubmed/30748011
http://dx.doi.org/10.1002/ijc.32205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767695/
https://www.ncbi.nlm.nih.gov/pubmed/30748011
http://dx.doi.org/10.1002/ijc.32205

Ejemplares similares